Stiefel Korea's Stieva-A cream acquires additional indication for treatment of photoaging

Published: 2004-08-09 06:56:00

Updated: 2004-08-09 06:56:00

Stiefel Korea has received from the Korea Food and Drug Administration an additional approval for its anti-acne cream, Stieva-A cream (trentinoin) for the first time in Korea, as a treatment to assist in reducing certain kinds of skin damage, such as fine wrinkles, spotty discoloration and rough ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK